Quick Answer
ImmunityBio, Inc. reported Stockholders Equity of -$500.47 million for the year ending 2025.
- ImmunityBio, Inc. showed a decrease of -2.3% in Stockholders Equity from 2024 to 2025.
- This data is from ImmunityBio, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: $126.52 million | Q3 2015: $362.93 million | Q1 2016: $344.50 million | Q2 2016: $327.36 million | Q3 2016: $310.89 million | Q1 2017: $278.37 million | Q2 2017: $252.92 million | Q3 2017: $237.70 million | Q1 2018: $200.36 million | Q2 2018: $181.63 million | Q3 2018: $162.09 million | Q1 2019: $167.81 million | Q2 2019: $151.27 million | Q3 2019: $135.96 million | Q1 2020: $102.60 million | Q2 2020: $169.65 million | Q3 2020: $148.62 million | Q1 2021: -$185.79 million | Q2 2021: -$157.94 million | Q3 2021: -$188.50 million | Q1 2022: -$335.64 million | Q2 2022: -$419.82 million | Q3 2022: -$426.70 million | Q1 2023: -$528.98 million | Q2 2023: -$642.12 million | Q3 2023: -$411.72 million | Q1 2024: -$692.01 million | Q2 2024: -$698.39 million | Q3 2024: -$745.15 million | Q1 2025: -$591.43 million | Q2 2025: -$570.75 million | Q3 2025: -$524.32 million.
- Over the full 13 years of available data (2013 to 2025), ImmunityBio, Inc.'s Stockholders Equity has declined by 13,228.1%.
- Historical annual values: Fiscal year 2025: -$500.47 million | Fiscal year 2024: -$489.10 million | Fiscal year 2023: -$586.99 million | Fiscal year 2022: -$447.33 million | Fiscal year 2021: -$242.17 million | Fiscal year 2020: -$119.81 million | Fiscal year 2019: $120.68 million | Fiscal year 2018: $146.01 million | Fiscal year 2017: $218.84 million | Fiscal year 2016: $293.42 million | Fiscal year 2015: $356.00 million | Fiscal year 2014: $57.59 million | Fiscal year 2013: -$3.76 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: